Plymouth Meeting based Geneos Therapeutics is developing DNA-based personalized therapeutic cancer vaccines
Founder and CEO Niranjan Sardesai describes why is believes a personalized approach is important and how Geneos is working on the technology, which is currently in phase 2 in advanced liver cancer.
Comentários